Compare VCEL & QFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCEL | QFIN |
|---|---|---|
| Founded | 1989 | 2016 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 1996 | 2018 |
| Metric | VCEL | QFIN |
|---|---|---|
| Price | $33.54 | $14.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $58.50 | $36.85 |
| AVG Volume (30 Days) | 423.1K | ★ 1.2M |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.33% |
| EPS Growth | ★ 60.00 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $276,259,000.00 | N/A |
| Revenue This Year | $19.09 | $16.35 |
| Revenue Next Year | $17.96 | N/A |
| P/E Ratio | $105.00 | ★ $2.21 |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $29.24 | $14.04 |
| 52 Week High | $49.10 | $48.94 |
| Indicator | VCEL | QFIN |
|---|---|---|
| Relative Strength Index (RSI) | 37.24 | 38.66 |
| Support Level | $29.59 | $14.04 |
| Resistance Level | $38.48 | $15.46 |
| Average True Range (ATR) | 1.47 | 0.55 |
| MACD | -0.36 | 0.05 |
| Stochastic Oscillator | 9.47 | 19.54 |
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Qfin Holdings Inc Formerly Qifu Technology Inc is a Credit-Tech platform in China. It provides credit services more accessible and personalized to consumers and SMEs through Credit-Tech services to financial institutions, whereby it deploys its technology solutions to help financial institutions identify the diversified needs of consumers and SMEs, effectively access prospective borrowers that are creditworthy through multi-channels, enhance credit assessment on prospective borrowers, and manage credit risks and improve collection strategies and efficiency, among others.